Michael S. Rosol - Dec 27, 2021 Form 4/A - Amendment Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role
Chief Medical Officer
Signature
/s/ Erika L. Eves for Michael S. Rosol, by power of attorney
Stock symbol
NAVB
Transactions as of
Dec 27, 2021
Transactions value $
$100
Form type
4/A - Amendment
Date filed
3/8/2022, 03:01 PM
Date Of Original Report
Dec 29, 2021
Next filing
Jan 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAVB Stock Option Award $100 +100K $0.00* 100K Dec 27, 2021 Common Stock 100K $1.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest quarterly over a four-year period beginning on April 1, 2022.